Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment

  • 0Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, USA.

|

|

Summary

This summary is machine-generated.

Ferroptosis, a cell death process, is linked to intestinal diseases like colorectal cancer and inflammatory bowel disease. Targeting ferroptosis offers potential new therapies for these conditions.

Area Of Science

  • Cell Biology
  • Pathophysiology
  • Oncology

Background

  • Ferroptosis is a regulated cell death (RCD) pathway characterized by iron accumulation and lipid peroxidation.
  • Since its 2012 discovery, ferroptosis has been implicated in the pathogenesis of numerous diseases.
  • Ferroptosis plays a complex role in intestinal dysfunction, acting as both a promoter and inhibitor depending on context.

Purpose Of The Study

  • To review the role of ferroptosis in intestinal diseases.
  • To explore therapeutic strategies targeting the ferroptosis pathway for colorectal cancer (CRC) and inflammatory bowel disease (IBD).

Main Methods

  • Literature review of studies on ferroptosis, CRC, and IBD.
  • Analysis of mechanisms linking ferroptosis to intestinal disease pathogenesis.
  • Identification of potential therapeutic targets within the ferroptosis pathway.

Main Results

  • Ferroptosis is increasingly recognized as a significant factor in intestinal disease development.
  • Specific cell types and disease contexts dictate whether ferroptosis exacerbates or ameliorates intestinal conditions.
  • The ferroptosis pathway presents promising avenues for novel therapeutic interventions in CRC and IBD.

Conclusions

  • Targeting ferroptosis holds significant therapeutic potential for managing prevalent intestinal diseases like CRC and IBD.
  • Further research into ferroptosis mechanisms can unlock innovative treatment strategies.
  • Understanding the nuanced role of ferroptosis is crucial for developing effective therapies.

Related Concept Videos

Necrosis 01:16

4.4K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Targeted Cancer Therapies 02:57

7.5K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Inflammatory Bowel Disease  V: Surgical Management 01:21

128

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Strictureplasty
Proctocolectomy or total colectomy with ileostomy
Restorative proctocolectomy with Ileal pouch-anal anastomosis

Drugs for Treatment of Ulcerative Colitis in IBD 01:29

129

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents 01:29

145

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Cancer Therapies 02:49

7.6K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...